Date: 2017-02-16
Type of information: Nomination
Compound: senior vice-president of technical operations
Company: Catalyst Biosciences (USA - CA)
Therapeutic area: Rare diseases - Genetic diseases - Hematological diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On February 16, 2017, Catalyst Bioscience announced that Andrew Hetherington has been promoted to Senior Vice President of Technical Operations. Mr. Hetherington joined Catalyst in September 2015 and has successfully led the Pfizer-to-Catalyst technology transfer of the company’s next-generation Factor VIIa clinical candidate, and has been instrumental in advancing the company’s next generation Factor IX clinical manufacture and associated program activities.
Financial terms:
Latest news:
Is general: Yes
